ICD-9-CM Volume 2 Index entries containing back-references to
285.9:
- Anemia 285.9
with![](/images/vertical.gif)
disorder of![](/images/vertical.gif)
![](/images/vertical.gif)
anaerobic glycolysis 282.3![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
pentose phosphate pathway 282.2![](/images/note.png)
![](/images/vertical.gif)
koilonychia 280.9![](/images/note.png)
6-phosphogluconic dehydrogenase deficiency 282.2![](/images/note.png)
Addison's (pernicious) 281.0![](/images/note.png)
Addison-Biermer (pernicious) 281.0![](/images/note.png)
amino acid deficiency 281.4![](/images/note.png)
antineoplastic chemotherapy induced 285.3![](/images/note.png)
atypical (primary) 285.9
autohemolysis of Selwyn and Dacie (type I) 282.2![](/images/note.png)
autoimmune hemolytic 283.0![](/images/note.png)
Biermer's (pernicious) 281.0![](/images/note.png)
blood loss (chronic) 280.0![](/images/note.png)
brickmakers' (see also Ancylostomiasis) 126.9![](/images/note.png)
chronica congenita aregenerativa 284.01![](/images/note.png)
chronic 285.9
complicating pregnancy or childbirth 648.2![](/images/note.png)
congenital (following fetal blood loss) 776.5![](/images/note.png)
![](/images/vertical.gif)
aplastic 284.01![](/images/note.png)
![](/images/vertical.gif)
due to isoimmunization NEC 773.2![](/images/note.png)
![](/images/vertical.gif)
Heinz-body 282.7![](/images/note.png)
![](/images/vertical.gif)
hereditary hemolytic NEC 282.9![](/images/note.png)
![](/images/vertical.gif)
nonspherocytic![](/images/vertical.gif)
pernicious 281.0![](/images/note.png)
![](/images/vertical.gif)
spherocytic (see also Spherocytosis) 282.0![](/images/note.png)
Cooley's (erythroblastic) 282.44![](/images/note.png)
crescent - see Disease, sickle-cell
Dacie's (nonspherocytic)
Davidson's (refractory) 284.9![](/images/note.png)
Diamond-Blackfan (congenital hypoplastic) 284.01![](/images/note.png)
drepanocytic (see also Disease, sickle-cell) 282.60![](/images/note.png)
due to![](/images/vertical.gif)
antineoplastic chemotherapy 285.3![](/images/note.png)
![](/images/vertical.gif)
blood loss (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
chemotherapy, antineoplastic 285.3![](/images/note.png)
![](/images/vertical.gif)
defect of Embden-Meyerhof pathway glycolysis 282.3![](/images/note.png)
![](/images/vertical.gif)
disorder of glutathione metabolism 282.2![](/images/note.png)
![](/images/vertical.gif)
drug - see Anemia, by type (see also Table of Drugs and Chemicals)![](/images/vertical.gif)
![](/images/vertical.gif)
chemotherapy, antineoplastic 285.3![](/images/note.png)
![](/images/vertical.gif)
fetal blood loss 776.5![](/images/note.png)
![](/images/vertical.gif)
fish tapeworm (D. latum) infestation 123.4![](/images/note.png)
![](/images/vertical.gif)
glutathione metabolism disorder 282.2![](/images/note.png)
![](/images/vertical.gif)
hemorrhage (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
hexose monophosphate (HMP) shunt deficiency 282.2![](/images/note.png)
![](/images/vertical.gif)
impaired absorption 280.9![](/images/note.png)
![](/images/vertical.gif)
loss of blood (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
myxedema 244.9![](/images/note.png)
![](/images/vertical.gif)
Necator americanus 126.1![](/images/note.png)
![](/images/vertical.gif)
prematurity 776.6![](/images/note.png)
![](/images/vertical.gif)
selective vitamin B12 malabsorption with proteinuria 281.1![](/images/note.png)
Dyke-Young type (secondary)
dyserythropoietic (congenital) (types I, II, III) 285.8![](/images/note.png)
dyshemopoietic (congenital) 285.8![](/images/note.png)
Egypt (see also Ancylostomiasis) 126.9![](/images/note.png)
elliptocytosis (see also Elliptocytosis) 282.1![](/images/note.png)
enzyme deficiency, drug-induced 282.2![](/images/note.png)
epidemic (see also Ancylostomiasis) 126.9![](/images/note.png)
erythroblastic![](/images/vertical.gif)
familial 282.44![](/images/note.png)
![](/images/vertical.gif)
fetus or newborn (see also Disease, hemolytic) 773.2![](/images/note.png)
erythrocytic glutathione deficiency 282.2![](/images/note.png)
erythropoietin-resistant (EPO resistant anemia) 285.21![](/images/note.png)
essential 285.9
Faber's (achlorhydric anemia) 280.9![](/images/note.png)
factitious (self-induced bloodletting) 280.0![](/images/note.png)
familial erythroblastic (microcytic) 282.44![](/images/note.png)
Fanconi's (congenital pancytopenia) 284.09![](/images/note.png)
fetal 678.0![](/images/note.png)
![](/images/vertical.gif)
following blood loss, affecting newborn 776.5![](/images/note.png)
fetus or newborn![](/images/vertical.gif)
due to![](/images/vertical.gif)
following fetal blood loss 776.5![](/images/note.png)
fish tapeworm (D. latum) infestation 123.4![](/images/note.png)
folate (folic acid) deficiency 281.2![](/images/note.png)
folate malabsorption, congenital 281.2![](/images/note.png)
folic acid deficiency 281.2![](/images/note.png)
general 285.9
glucose-6-phosphate dehydrogenase deficiency 282.2![](/images/note.png)
glutathione-reductase deficiency 282.2![](/images/note.png)
Heinz-body, congenital 282.7![](/images/note.png)
hemoglobin deficiency 285.9
hemolytic 283.9![](/images/note.png)
![](/images/vertical.gif)
acquired 283.9![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
with hemoglobinuria NEC 283.2![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
autoimmune (cold type) (idiopathic) (primary) (secondary) (symptomatic) (warm type) 283.0![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
due to![](/images/vertical.gif)
![](/images/vertical.gif)
![](/images/vertical.gif)
cold reactive antibodies 283.0![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
![](/images/vertical.gif)
drug exposure 283.0![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
![](/images/vertical.gif)
warm reactive antibodies 283.0![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
fragmentation 283.19![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
idiopathic (chronic) 283.9![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
infectious 283.19![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
non-autoimmune 283.10![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
toxic 283.19![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
traumatic cardiac 283.19![](/images/note.png)
![](/images/vertical.gif)
acute 283.9![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
due to enzyme deficiency NEC 282.3![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
fetus or newborn (see also Disease, hemolytic) 773.2![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
Lederer's (acquired infectious hemolytic anemia) 283.19![](/images/note.png)
![](/images/vertical.gif)
autoimmune (acquired) 283.0![](/images/note.png)
![](/images/vertical.gif)
chronic 282.9![](/images/note.png)
![](/images/vertical.gif)
cold type (secondary) (symptomatic) 283.0![](/images/note.png)
![](/images/vertical.gif)
congenital (spherocytic) (see also Spherocytosis) 282.0![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
nonspherocytic - see Anemia, hemolytic, nonspherocytic, congenital
![](/images/vertical.gif)
drug-induced 283.0![](/images/note.png)
![](/images/vertical.gif)
due to![](/images/vertical.gif)
![](/images/vertical.gif)
cardiac conditions 283.19![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
drugs 283.0![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
enzyme deficiency NEC 282.3![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
presence of shunt or other internal prosthetic device 283.19![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
thrombotic thrombocytopenic purpura 446.6![](/images/note.png)
![](/images/vertical.gif)
elliptocytotic (see also Elliptocytosis) 282.1![](/images/note.png)
![](/images/vertical.gif)
familial 282.9![](/images/note.png)
![](/images/vertical.gif)
hereditary 282.9![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
due to enzyme deficiency NEC 282.3![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
specified NEC 282.8![](/images/note.png)
![](/images/vertical.gif)
idiopathic (chronic) 283.9![](/images/note.png)
![](/images/vertical.gif)
infectious (acquired) 283.19![](/images/note.png)
![](/images/vertical.gif)
mechanical 283.19![](/images/note.png)
![](/images/vertical.gif)
microangiopathic 283.19![](/images/note.png)
![](/images/vertical.gif)
nonautoimmune 283.10![](/images/note.png)
![](/images/vertical.gif)
nonspherocytic![](/images/vertical.gif)
of or complicating pregnancy 648.2![](/images/note.png)
![](/images/vertical.gif)
resulting from presence of shunt or other internal prosthetic device 283.19![](/images/note.png)
![](/images/vertical.gif)
secondary 283.19![](/images/note.png)
![](/images/vertical.gif)
sickle-cell - see Disease, sickle-cell![](/images/vertical.gif)
Stransky-Regala type (Hb-E) (see also Disease, hemoglobin) 282.7![](/images/note.png)
![](/images/vertical.gif)
symptomatic 283.19![](/images/note.png)
![](/images/vertical.gif)
toxic (acquired) 283.19![](/images/note.png)
![](/images/vertical.gif)
uremic (adult) (child) 283.11![](/images/note.png)
![](/images/vertical.gif)
warm type (secondary) (symptomatic) 283.0![](/images/note.png)
hemorrhagic (chronic) 280.0![](/images/note.png)
hereditary erythroblast multinuclearity-positive acidified serum test 285.8![](/images/note.png)
Herrick's (hemoglobin S disease) 282.61![](/images/note.png)
hexokinase deficiency 282.3![](/images/note.png)
hookworm (see also Ancylostomiasis) 126.9![](/images/note.png)
hypochromic (idiopathic) (microcytic) (normoblastic) 280.9![](/images/note.png)
![](/images/vertical.gif)
with iron loading 285.0![](/images/note.png)
![](/images/vertical.gif)
due to blood loss (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
familial sex linked 285.0![](/images/note.png)
![](/images/vertical.gif)
pyridoxine-responsive 285.0![](/images/note.png)
hypoplasia, red blood cells 284.81![](/images/note.png)
hypoplastic (idiopathic) 284.9![](/images/note.png)
idiopathic 285.9
in (due to) (with)
infantile 285.9
infective, infectional 285.9
intertropical (see also Ancylostomiasis) 126.9![](/images/note.png)
iron (Fe) deficiency 280.9![](/images/note.png)
![](/images/vertical.gif)
due to blood loss (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
of or complicating pregnancy 648.2![](/images/note.png)
![](/images/vertical.gif)
specified NEC 280.8![](/images/note.png)
Jaksch's (pseudoleukemia infantum) 285.8![](/images/note.png)
Joseph-Diamond-Blackfan (congenital hypoplastic) 284.01![](/images/note.png)
Lederer's (acquired infectious hemolytic anemia) 283.19![](/images/note.png)
leptocytosis (hereditary) 282.40![](/images/note.png)
leukoerythroblastic 284.2![](/images/note.png)
malabsorption (familial), selective B12 with proteinuria 281.1![](/images/note.png)
malarial (see also Malaria) 084.6![](/images/note.png)
malignant (progressive) 281.0![](/images/note.png)
marsh (see also Malaria) 084.6![](/images/note.png)
microangiopathic hemolytic 283.19![](/images/note.png)
microcytic (hypochromic) 280.9![](/images/note.png)
miners' (see also Ancylostomiasis) 126.9![](/images/note.png)
myelophthisic (normocytic) 284.2![](/images/note.png)
newborn (see also Disease, hemolytic) 773.2![](/images/note.png)
![](/images/vertical.gif)
due to isoimmunization (see also Disease, hemolytic) 773.2![](/images/note.png)
![](/images/vertical.gif)
late, due to isoimmunization 773.5![](/images/note.png)
![](/images/vertical.gif)
posthemorrhagic 776.5![](/images/note.png)
nonspherocytic hemolytic - see Anemia, hemolytic, nonspherocytic
normocytic (infectional) (not due to blood loss) 285.9![](/images/vertical.gif)
due to blood loss (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
myelophthisic 284.2![](/images/note.png)
nutritional (deficiency) 281.9![](/images/note.png)
![](/images/vertical.gif)
with![](/images/vertical.gif)
![](/images/vertical.gif)
poor iron absorption 280.9![](/images/note.png)
![](/images/vertical.gif)
![](/images/vertical.gif)
specified deficiency NEC 281.8![](/images/note.png)
![](/images/vertical.gif)
due to inadequate dietary iron intake 280.1![](/images/note.png)
![](/images/vertical.gif)
megaloblastic (of infancy) 281.2![](/images/note.png)
of chronic
of or complicating pregnancy 648.2![](/images/note.png)
![](/images/vertical.gif)
affecting fetus or newborn 760.8![](/images/note.png)
orotic aciduric (congenital) (hereditary) 281.4![](/images/note.png)
ovalocytosis (hereditary) (see also Elliptocytosis) 282.1![](/images/note.png)
paludal (see also Malaria) 084.6![](/images/note.png)
pentose phosphate pathway deficiency 282.2![](/images/note.png)
pernicious (combined system disease) (congenital) (dorsolateral spinal degeneration) (juvenile) (myelopathy) (neuropathy) (posterior sclerosis) (primary) (progressive) (spleen) 281.0![](/images/note.png)
![](/images/vertical.gif)
of or complicating pregnancy 648.2![](/images/note.png)
pleochromic 285.9
posthemorrhagic (chronic) 280.0![](/images/note.png)
postoperative![](/images/vertical.gif)
due to (acute) blood loss 285.1![](/images/note.png)
![](/images/vertical.gif)
other 285.9
pressure 285.9
primary 285.9
profound 285.9
progressive 285.9
pseudoleukemica infantum 285.8![](/images/note.png)
pyridoxine-responsive (hypochromic) 285.0![](/images/note.png)
pyruvate kinase (PK) deficiency 282.3![](/images/note.png)
refractoria sideroblastica 238.72![](/images/note.png)
Rietti-Greppi-Micheli (thalassemia minor) 282.46![](/images/note.png)
secondary (to) 285.9![](/images/vertical.gif)
blood loss (chronic) 280.0![](/images/note.png)
![](/images/vertical.gif)
hemorrhage 280.0![](/images/note.png)
![](/images/vertical.gif)
inadequate dietary iron intake 280.1![](/images/note.png)
septic 285.9
sickle-cell (see also Disease, sickle-cell) 282.60![](/images/note.png)
sideroblastic (acquired) (any type) (congenital) (drug-induced) (due to disease) (hereditary) (primary) (secondary) (sex-linked hypochromic) (vitamin B6 responsive) 285.0![](/images/note.png)
sideropenic 280.9![](/images/note.png)
![](/images/vertical.gif)
due to blood loss (chronic) 280.0![](/images/note.png)
spherocytic (hereditary) (see also Spherocytosis) 282.0![](/images/note.png)
target cell (oval) 285.8![](/images/note.png)
![](/images/vertical.gif)
with thalassemia - see Thalassemia
thrombocytopenic (see also Thrombocytopenia) 287.5![](/images/note.png)
triosephosphate isomerase deficiency 282.3![](/images/note.png)
tropical, macrocytic 281.2![](/images/note.png)
tuberculous (see also Tuberculosis) 017.9![](/images/note.png)
vitamin
von Jaksch's (pseudoleukemia infantum) 285.8![](/images/note.png)
Witts' (achlorhydric anemia) 280.9![](/images/note.png)
Zuelzer (-Ogden) (nutritional megaloblastic anemia) 281.2![](/images/note.png)
- Deficiency, deficient
hemoglobin (see also Anemia) 285.9
- Erythrocytopenia 285.9
- Erythropenia 285.9
- Findings, (abnormal), without diagnosis (examination) (laboratory test) 796.4
![](/images/note.png)
hematocrit
hemoglobin
- Hemoglobin - see also condition
low NEC 285.9
- Hydremia 285.9
- Impoverished blood 285.9
- Low
hemoglobin 285.9
- Normocytic anemia (infectional) 285.9
due to blood loss (chronic) 280.0![](/images/note.png)
- Oligemia 285.9
- Oligocythemia 285.9
- Spanemia 285.9